Generalized Tonic-Clonic Seizures
Generalized tonic-clonic seizures are a type of seizure that affects both sides of the brain, leading to loss of consciousness and violent muscle contractions.
Epilepsy: Long-term Study of XEN1101
We are examining the safety and effectiveness of XEN1101 for adults with epilepsy. This study looks at how well it reduces seizures and improves quality of life over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Focal Epilepsy
Focal epilepsy involves seizures that start in one area of the brain, which can cause a variety of symptoms depending on the affected region.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female who is pregnant, breastfeeding, or planning to become pregnant in the next 6 months?
- Are you able to keep accurate seizure diaries?
- Have you had any medical conditions or ongoing issues from previous studies that could make participating unsafe?
- Are you planning to enter another clinical study with a different investigational drug during this study?
- Are you able to understand and follow verbal and written instructions from the study team?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Azetukalner
Xpf-010
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Universitaet Innsbruck
University Clinic of Neurology
Innsbruck, Austria
Johannes Kepler University Linz
University Clinic for Pediatrics and Adolescent Medicine, Med. Campus IV
Linz, Austria
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
University Clinic of Neurology, neurological Intensive care and Neurorehabilitation of the PMU
Salzburg, Austria
Sponsor: Xenon Pharmaceuticals Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.